These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression. Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485 [TBL] [Abstract][Full Text] [Related]
5. Auxilin Underlies Progressive Locomotor Deficits and Dopaminergic Neuron Loss in a Drosophila Model of Parkinson's Disease. Song L; He Y; Ou J; Zhao Y; Li R; Cheng J; Lin CH; Ho MS Cell Rep; 2017 Jan; 18(5):1132-1143. PubMed ID: 28147270 [TBL] [Abstract][Full Text] [Related]
6. CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling. Meng F; Guo Z; Hu Y; Mai W; Zhang Z; Zhang B; Ge Q; Lou H; Guo F; Chen J; Duan S; Gao Z Brain; 2019 Mar; 142(3):700-718. PubMed ID: 30689733 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a presymptomatic stage in a Drosophila Parkinson's disease model: Unveiling dopaminergic compensatory mechanisms. Molina-Mateo D; Fuenzalida-Uribe N; Hidalgo S; Molina-Fernández C; Abarca J; Zárate RV; Escandón M; Figueroa R; Tevy MF; Campusano JM Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2882-2890. PubMed ID: 28716706 [TBL] [Abstract][Full Text] [Related]
8. mGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson's Disease. Farmer K; Abd-Elrahman KS; Derksen A; Rowe EM; Thompson AM; Rudyk CA; Prowse NA; Dwyer Z; Bureau SC; Fortin T; Ferguson SSG; Hayley S Mol Neurobiol; 2020 Mar; 57(3):1418-1431. PubMed ID: 31754998 [TBL] [Abstract][Full Text] [Related]
9. Cellular and synaptic mechanisms for Parkinson's disease-related chronic pain. Lu JS; Chen QY; Chen X; Li XH; Zhou Z; Liu Q; Lin Y; Zhou M; Xu PY; Zhuo M Mol Pain; 2021; 17():1744806921999025. PubMed ID: 33784837 [TBL] [Abstract][Full Text] [Related]
10. Progressively disrupted somatodendritic morphology in dopamine neurons in a mouse Parkinson's model. Lynch WB; Tschumi CW; Sharpe AL; Branch SY; Chen C; Ge G; Li S; Beckstead MJ Mov Disord; 2018 Dec; 33(12):1928-1937. PubMed ID: 30440089 [TBL] [Abstract][Full Text] [Related]
12. Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice. Szego EM; Malz L; Bernhardt N; Rösen-Wolff A; Falkenburger BH; Luksch H Elife; 2022 Oct; 11():. PubMed ID: 36314770 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and dopamine metabolism converge via mitochondrial dysfunction in the mechanisms of neurodegeneration in Parkinson's disease. Nunes C; Laranjinha J Arch Biochem Biophys; 2021 Jun; 704():108877. PubMed ID: 33864752 [TBL] [Abstract][Full Text] [Related]
14. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons. Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688 [TBL] [Abstract][Full Text] [Related]
15. Impaired D2 receptor-dependent dopaminergic transmission in prefrontal cortex of awake mouse model of Parkinson's disease. Li M; Xu H; Chen G; Sun S; Wang Q; Liu B; Wu X; Zhou L; Chai Z; Sun X; Lu Y; Younus M; Zheng L; Zhu F; Jia H; Chen X; Wang C; Zhou Z Brain; 2019 Oct; 142(10):3099-3115. PubMed ID: 31504219 [TBL] [Abstract][Full Text] [Related]
16. Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration. Volpicelli F; Perrone-Capano C; Bellenchi GC; Colucci-D'Amato L; di Porzio U Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503161 [TBL] [Abstract][Full Text] [Related]
17. 5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease. Badillo-Ramírez I; Saniger JM; Rivas-Arancibia S Neurochem Int; 2019 Oct; 129():104514. PubMed ID: 31369776 [TBL] [Abstract][Full Text] [Related]
18. Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration. Zhang S; Wang R; Wang G ACS Chem Neurosci; 2019 Feb; 10(2):945-953. PubMed ID: 30592597 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity. Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998 [TBL] [Abstract][Full Text] [Related]
20. Dopamine depletion alters macroscopic network dynamics in Parkinson's disease. Shine JM; Bell PT; Matar E; Poldrack RA; Lewis SJG; Halliday GM; O'Callaghan C Brain; 2019 Apr; 142(4):1024-1034. PubMed ID: 30887035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]